[1,3]diazino[5,4-d]pyrimidines as HER2 inhibitors

AU2026220268A1Pending Publication Date: 2026-09-10BOEHRINGER INGELHEIM INT GMBH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
AU2026220268
Authority / Receiving Office
AU · AU
Patent Type
Applications
Current Assignee / Owner
Filing Date
2026-08-21
Publication Date
2026-09-10
Patent Text Reader

Abstract

[l,3]DIAZINO[5,4-d]PYRIMIDINES AS HER2 INHIBITORS Abstract The present invention relates to new [1,3]diazino[5,4-d]pyrimidines and derivatives of Formula (I), wherein the groups R1, R2, R3 and R4 have the meanings given in the claims and specification, their use as inhibitors of HER2 and its mutants, pharmaceutical compositions which contain such compounds and their use as medicaments, especially as agents for treatment and / or prevention of oncological diseases. R 0 RX 3 HN R² R N. N N. N (I) diseases. 20 26 22 02 68 21 A ug 2 02 6 2 0 2 6 2 2 0 2 6 8 2 1 2 0 2 6 A u g A b s t r a c t R 0 H N R ² R N N . N
Need to check novelty before this filing date? Find Prior Art